Rosiglitazone: a thunderstorm from scarce and frag... [Ann Intern Med. 2007]

Cited by 3 PubMed Central articles

Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.
Hirsch LJ. Mayo Clin Proc. 2009 Sep; 84(9):811-21.

[Mayo Clin Proc. 2009]
ReviewSafety and efficacy of rosiglitazone in the elderly diabetic patient.
Viljoen A, Sinclair A. Vasc Health Risk Manag. 2009; 5(1):389-95.

[Vasc Health Risk Manag. 2009]
ReviewCardiovascular outcomes in trials of oral diabetes medications: a systematic review.
Selvin E, Bolen S, Yeh HC, Wiley C, Wilson LM, Marinopoulos SS, Feldman L, Vassy J, Wilson R, Bass EB, et al. Arch Intern Med. 2008 Oct 27; 168(19):2070-80.

[Arch Intern Med. 2008]

Rosiglitazone (Avandia®, Avandaryl® (as a combination product containing rosiglitazone and glimepiride), Avandamet® (as a combination product containing rosiglitazone and metformin))
Rosiglitazone is used along with a diet and exercise program and sometimes with one or more other medications to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot con...
Source: AHFS Consumer Medication Information

Related Articles
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Your browsing activity is empty.

Activity recording is turned off.